Case Report
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 557-562
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.557
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Image of hepatic metastases on admission. Contrast-enhanced computed tomography scan showing multiple hepatic masses.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Clinical course of the patient. Bilirubin and carcinoembryonic antigen levels markedly decreased after four cycles of panitumumab monotherapy. CEA: Carcinoembryonic antigen.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Image of hepatic metastases after 4 cycles of panitumumab monotherapy. Contrast-enhanced computed tomography revealed decreased sizes of the hepatic masses.